Skip to main content
SpringerLink
Log in

Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”

  • Letter to the Editor
  • Published:
Drugs & Aging Aims and scope Submit manuscript

The Original Article was published on 12 February 2020

A Therapy in Practice to this article was published on 21 September 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bahat G, Ilhan B, Karan MA. Comment on “Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide”. Drugs Aging. 2020. https://doi.org/10.1007/s40266-020-00751-4.

    Article  PubMed  Google Scholar 

  2. Raterman HG, Lems WF. Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide. Drugs Aging. 2019;36(12):1061–72. https://doi.org/10.1007/s40266-019-00714-4.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Buckley L, Humphrey MB. Glucocorticoid-Induced Osteoporosis. N Engl J Med. 2018;379(26):2547–56. https://doi.org/10.1056/NEJMcp1800214.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Noordwest Ziekenhuisgroep, Postbus 501, 1800 AM, Alkmaar, The Netherlands

    Hennie G. Raterman

  2. Department of Rheumatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

    Willem F. Lems

  3. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, The Netherlands

    Willem F. Lems

Authors
  1. Hennie G. Raterman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Willem F. Lems
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hennie G. Raterman.

Ethics declarations

Funding

No funding was received for the preparation of this letter.

Conflicts of interest

Hennie G. Raterman has received an unrestricted educational grant from UCB, and consulting fees from Amgen, Cellgene and Sanof Genzyme. Willem F. Lems has received a grant from Pfzer, and consulting fees from MSD, Amgen, Lilly, Pfzer and UCB.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raterman, H.G., Lems, W.F. Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”. Drugs Aging 37, 239–240 (2020). https://doi.org/10.1007/s40266-020-00751-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-020-00751-4

Search

Navigation